Literature DB >> 7566573

Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction.

G B Fogazzi1, E Imbasciati, G Moroni, A Scalia, M J Mihatsch, C Ponticelli.   

Abstract

Seven patients with acute renal failure due to gross haematuria caused by glomerulonephritis are described. Gross haematuria lasting 4-40 days led to acute impairment of renal function of variable severity (peak plasma creatinine 1.3-12 mg/dl) and duration. While partial recovery of renal function occurred in all patients within few days, complete remission was observed only some months later. Three patients had IgA nephropathy (2 the primary form and 1 nephritis secondary to Schönlein-Henoch purpura), two patients had acute postinfectious glomerulonephritis, and two others had focal necrotizing (pauci-immune) glomerulonephritis. The glomerular changes seen in the renal biopsy were not enough to explain per se the renal function impairment. Tubular changes, however, were severe and consisted of tubular necrosis, erythrocyte casts, erythrocyte phagocytosis by tubular cells, accompanied by interstitial damage (oedema, red-cell extravasation, and inflammatory infiltrates). Study of the renal biopsies by immunofluorescence revealed no retrodiffusion of Tamm-Horsfall protein into the glomerular Bowman's space, a sign of obstructed tubular flow in any case. It is concluded that acute renal failure due to gross haematuria in glomerulonephritic patients may not occur only in IgA nephropathy, as reported so far, and is not associated with intratubular obstruction.

Entities:  

Mesh:

Year:  1995        PMID: 7566573

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury.

Authors:  B A Vogt; T P Shanley; A Croatt; J Alam; K J Johnson; K A Nath
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Atypical triad of IgA nephropathy: reversible acute kidney injury, gross hematuria, and severe bilateral flank pain.

Authors:  Susan Kim; Warren Chang
Journal:  CEN Case Rep       Date:  2013-12-17

3.  Comparison of prominent glomerular injury and prominent tubular injury in immunoglobulin A nephropathy.

Authors:  Yao-Ko Wen
Journal:  Int Urol Nephrol       Date:  2009-12-18       Impact factor: 2.370

4.  IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.

Authors:  Hernando Trujillo; Justo Sandino; Teresa Cavero; Fernando Caravaca-Fontán; Eduardo Gutiérrez; Ángel M Sevillano; Amir Shabaka; Gema Fernández-Juárez; Pablo Rodríguez Doyágüez; Rocío Gimena Muñoz; Leonardo Calle García; Virginia Cabello; José Manuel Muñoz-Terol; Ana García Santiago; Oscar Toldos; Juan Antonio Moreno; Manuel Praga
Journal:  Kidney Int Rep       Date:  2022-01-19

5.  Acute renal failure associated with Gemella haemolysans pneumonia.

Authors:  Michael Eisenhut; Caroline Jones; David Hughes; Simon Herrington; George Kokai
Journal:  Pediatr Nephrol       Date:  2004-01-24       Impact factor: 3.714

Review 6.  An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.

Authors:  Ron Hogg
Journal:  Pediatr Nephrol       Date:  2021-05-13       Impact factor: 3.714

7.  Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases.

Authors:  Léonard Golbin; Cécile Vigneau; Guy Touchard; Eric Thervet; Jean-Michel Halimi; Théophile Sawadogo; Nathan Lagoutte; Pascale Siohan; Elie Zagdoun; Alexandre Hertig; Nathalie Rioux-Leclercq; Thierry Frouget
Journal:  Clin Kidney J       Date:  2017-02-08

8.  Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Paula F Orlandi; Naohiko Fujii; Jason Roy; Hsiang-Yu Chen; L Lee Hamm; James H Sondheimer; Jiang He; Michael J Fischer; Hernan Rincon-Choles; Geetha Krishnan; Raymond Townsend; Tariq Shafi; Chi-Yuan Hsu; John W Kusek; John T Daugirdas; Harold I Feldman
Journal:  BMC Nephrol       Date:  2018-06-26       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.